Somatostatin Blocks GHRP's Ability to Activate the Brain's GH Control Center
Central somatostatin (octreotide) attenuated the GH secretagogue-induced activation of arcuate nucleus neurons, demonstrating that somatostatin can oppose GHRP action at the hypothalamic level.
Quick Facts
What This Study Found
Octreotide (somatostatin analog) attenuated GH secretagogue-induced Fos expression in the arcuate nucleus, showing somatostatin opposes GHRP action centrally.
Key Numbers
How They Did This
Conscious male rats received IV octreotide (100 µg) or saline 10 minutes before IV GH secretagogue injection. Brains were processed for Fos protein immunohistochemistry.
Why This Research Matters
Understanding that somatostatin can block GHRP effects in the brain explains why high somatostatin states (like elevated blood sugar) can reduce GHRP efficacy.
The Bigger Picture
This finding explains why GHRPs work best when somatostatin tone is low (fasting, nighttime) and less well after meals or in high-glucose states.
What This Study Doesn't Tell Us
Animal study using pharmacological somatostatin analog (octreotide) at a specific dose. Natural somatostatin dynamics may differ. Fos expression is an indirect marker.
Questions This Raises
- ?Is the somatostatin-GHRP interaction at the hypothalamus clinically significant?
- ?Can timing GHRP administration around somatostatin fluctuations optimize GH response?
Trust & Context
- Key Stat:
- Central GHRP blockade by somatostatin Octreotide pre-treatment significantly reduced GHRP-induced arcuate nucleus activation
- Evidence Grade:
- Moderate animal evidence with clear pharmacological demonstration in conscious rats.
- Study Age:
- Published in 1997, informing current understanding of optimal GHRP timing relative to meals and blood sugar.
- Original Title:
- Attenuation of the growth hormone secretagogue induction of Fos protein in the rat arcuate nucleus by central somatostatin action.
- Published In:
- Neuroendocrinology, 66(3), 188-94 (1997)
- Authors:
- Dickson, S L(8), Viltart, O(2), Bailey, A R(6), Leng, G
- Database ID:
- RPEP-00404
Evidence Hierarchy
Tests effects in animals (usually mice or rats), not humans.
What do these levels mean? →Frequently Asked Questions
Why does somatostatin matter for GHRP users?
Somatostatin is the body's natural GH suppressor. When somatostatin levels are high (after meals, high blood sugar), it opposes GHRP effects at both the pituitary and brain. This is why GHRPs work best when taken fasting.
What is octreotide?
Octreotide (Sandostatin) is a long-acting synthetic version of somatostatin used medically to suppress hormone secretion. In this study it was used as a research tool to demonstrate somatostatin's opposition to GHRP effects.
Read More on RethinkPeptides
Cite This Study
https://rethinkpeptides.com/research/RPEP-00404APA
Dickson, S L; Viltart, O; Bailey, A R; Leng, G. (1997). Attenuation of the growth hormone secretagogue induction of Fos protein in the rat arcuate nucleus by central somatostatin action.. Neuroendocrinology, 66(3), 188-94.
MLA
Dickson, S L, et al. "Attenuation of the growth hormone secretagogue induction of Fos protein in the rat arcuate nucleus by central somatostatin action.." Neuroendocrinology, 1997.
RethinkPeptides
RethinkPeptides Research Database. "Attenuation of the growth hormone secretagogue induction of ..." RPEP-00404. Retrieved from https://rethinkpeptides.com/research/dickson-1997-attenuation-of-the-growth
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.